Found: 8
Select item for more details and to access through your institution.
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 55, doi. 10.1159/000450712
- By:
- Publication type:
- Article
The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 48, doi. 10.1159/000452143
- By:
- Publication type:
- Article
Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 39, doi. 10.1159/000448005
- By:
- Publication type:
- Article
Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 31, doi. 10.1159/000449527
- By:
- Publication type:
- Article
Dosimetric Improvements with a Novel Breast Stereotactic Radiotherapy Device for Delivery of Preoperative Partial-Breast Irradiation.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 21, doi. 10.1159/000449388
- By:
- Publication type:
- Article
Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 14, doi. 10.1159/000449505
- By:
- Publication type:
- Article
Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift.
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 3, doi. 10.1159/000450650
- By:
- Publication type:
- Article
Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible?
- Published in:
- Oncology, 2017, v. 92, n. 1, p. 1, doi. 10.1159/000452161
- By:
- Publication type:
- Article